2707Formosa International Hotels Corporation

🇹🇼 Tayvan Borsası
169.50
TWD
Analysis Scores
Lothien Robustness Score?
77/100
Very Strong
Neden bu skor?
Damodaran ?
66/100
Dalio Risk ?
77/100
Piotroski ?
6/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
NT$99.6
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
56/100
Lothien Sağlamlık: Orta (56/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Olumlu | Pozitif: 5 | Negatif: 3 | Nötr: 3
Net Kâr Pozitif
Son çeyrekte NT$369M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-49.5 geriledi (NT$730M → NT$369M). Kısa vadede olumsuz sinyal.
3 Çeyrek Üst Üste Düşüş
Son 3 çeyrek üst üste kâr düşüyor. Aşağı trend endişe verici. Sonraki çeyreğe dikkat.
Yüksek Net Kâr Marjı
Net kâr marjı %22.1. Her 100NT$ satıştan 22NT$ kâr kalıyor.
Güçlü Nakit Üretimi
Serbest nakit akışı (NT$1.5B) kârın %400'sini nakit olarak üretiyor. Kâr kalitesi yüksek.
FAVÖK Düşüşü
FAVÖK çeyreklik %-40.7 düştü. Operasyonel performans zayıflıyor.
Makul F/K
Trailing F/K: 11.7. Makul değerleme aralığında.
Yüksek PD/DD
PD/DD: 5.55. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek ROE
Özkaynak getirisi (ROE): %41.6. Sermaye verimli kullanılıyor.
Lothien Sağlamlık Skoru: 77/100
Bileşik algoritma değerlendirmesine göre şirketin finansal yapısı güçlü görünüyor.
Mevsimsel Etki
Çeyreklik düşüş (%-49.5) ama yıllık bazda artış (%+18.3). Bu muhtemelen mevsimsel bir düşüş.

Data date 2026-11-19 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-19
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Düşük
252 days
Annual Volatility ?
%12.1
VaR 95% ?
%1.30
daily max loss
VaR 99% ?
%1.82
daily max loss
CVaR 95% ?
%1.82
expected loss (tail)
Max Drawdown ?
%12.9
11.11.2025 → 30.04.2026
Skewness ?
-1.67
Parametrik%1.30
Historik%1.16
Cornish-Fisher%1.40
Return Distribution
Valuation
Potential?
+12.3%
ROIC ?
23.1%
DCF Value ?
240.52
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-6.8 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 181.78 TWD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %22.1
Net profit margin %22.1 — very strong. Compared to previous quarter -15.4 point decrease.
ROE - Return on Equity (TTM) %41.6
ROE %41.6 — high return on equity.
EBITDA Margin %38.9
EBITDA margin %38.9 — operationally very efficient.
Gross Profit Margin %33.5
Gross profit per revenue %33.5. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %25.5
TTM Free Cash Flow is %25.5'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio 11.7x Sector: 14.6x
F/K 11.7x — sector median (14.6x) near reasonable levels.
P/B Ratio 5.55x Sector: 3.37x
PD/DD 5.55x — sector median's %65 above. Expensive book value.
EV/EBITDA 8.0x Sector: 10.1x
EV/EBITDA 8.0x — sector median (10.1x) in line.
Indebtedness
Current Ratio 1.54x
Current ratio 1.54x — can comfortably cover short-term debts.
Net Debt / EBITDA 1.1x
Net Debt/EBITDA 1.1x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.85x
Debt/Equity 0.85x — moderate financial leverage.
Interest Coverage 49.5x
Interest coverage 49.5x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+5.3
Revenue YoY %5.3 grew — positive but slow growth.
Net Profit Growth (YoY) %+18.3
Net profit YoY %18.3 increased — positive but moderate growth.
Score Explanations
Lothien Robustness
77/100
Very strong robustness score (77/100). Damodaran valuation, Dalio risk analysis and balance sheet quality criteria are largely met.
Very Strong
Potential
+12.3%
Plus %12.3 expected value (190.43) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 223.90 | P/B target: 113.83 | EV/EBITDA target: 214.68 | DCF target: 240.52
Damodaran Valuation
66/100
Moderate Damodaran score (66/100). ROIC (%23.1) – WACC (%10.2) difference +12.9 bps. Value creation capacity limited.
Strong
Dalio Risk Analysis
77/100
Low debt risk (77/100). Interest coverage ratio 49.5x — strong. Debt/EBITDA 1.1x — in healthy range.
Leverage: 77/100 | Debt Service: 89/100 | Quality: 99/100
ROIC - Return on Capital
%23.1
ROIC (%23.1) cost of capital 12.9 bps above → company creates value.
WACC: %10.2
DCF Discounted Cash Flow
240.52
DCF modeli 240.52 target value produced — compared to current price %41.9 undervalued.
Current price: 169.50
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
6/9
Moderate Piotroski (6/9). Some balance sheet criteria met, some missing. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
NT$99.6
Expensive
⚖️ Sector Comparison
P/E Ratio
11.7x vs 14.6x
Sector median's %19 below — cheap
P/B Ratio
5.55x vs 3.37x
Compared to sector %65 more expensive (by book value)
EV/EBITDA
8.0x vs 10.1x
Compared to sector %21 lower EV/EBITDA
ROIC vs WACC
%23.1 vs %10.2 WACC
ROIC 12.9 bps above cost of capital
Net Profit Margin (TTM)
%26.3 vs %42.9 EBITDA margin
TTM net profit margin %26.3
TRAMA-99 Trend — Downtrend
Price (169.50), TRAMA-99 line's %6.8 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 169.50
TRAMA: 181.78
Difference: %-6.8
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
2707 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.